EnQuest (LSE: ENQ) full-year 2025 results: Production up 5.4%, dividend raised as South East Asia pivot reshapes growth outlook
Can Southland Holdings, Inc. turn water and data center demand into a cleaner growth story? (NYSE American: SLND)
Read More 2 minute read Pharma Industry News Novartis’ Sandoz gains EC approval for biosimilar Hyrimoz across multiple therapeutic areas In a significant advancement for biopharmaceuticals, Novartis’ division Sandoz has secured approval from the European Commission (EC) for… bypharmanewsdailyJuly 29, 2018
